Bacui Tech FY2025 net profit rises 45.9% to SGD 0.4 million

Reuters
02/27
<a href="https://laohu8.com/S/YYB.SI">Bacui Tech</a> FY2025 net profit rises 45.9% to SGD 0.4 million

Bacui Technologies International Ltd. (Bacui) reported FY2025 revenue of SGD 60.3 million (up 7.6%) and total profit of SGD 0.4 million (up 45.9%), with profit attributable to shareholders of SGD 0.4 million (up 47.1%). For 2H FY2025, revenue was SGD 29.3 million (down 1.4%) and total profit was SGD 0.07 million (down 69.1%). FY2025 other income was SGD 0.3 million (down 25.3%), while total expenses were SGD 59.6 million (up 6.8%); materials and consumables rose to SGD 9.4 million (up 95.2%) and employee compensation was SGD 49.2 million (down 1.0%). Bacui ended FY2025 with cash and cash equivalents of SGD 8.7 million, net assets of SGD 8.3 million, and recorded FY2025 net cash used in operating activities of SGD 1.8 million. The company said FY2025 revenue growth was mainly driven by catering outsourcing revenue of SGD 7.3 million (up 45.6%) and labour outsourcing revenue of SGD 51.7 million (up 3.3%). Looking ahead, Bacui said it will pursue geographic expansion and strategic collaborations in China, and noted preliminary steps toward drone-enabled transportation solutions for medical supplies that commenced in December 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bacui Technologies International Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: CBLE2ZF2ZB1I61YG) on February 27, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10